A NEW IDENTITY, SAME PURPOSE.

Conduct Research Inc. is adopting MDTrials CRO as its public-facing brand. Conduct Research Inc. continues to hold and perform its existing contracts, study obligations and regulatory responsibilities. Existing conductresearch.ca email addresses will continue to operate during the transition.

MDTrials CRO provides Canada-focused clinical development and trial execution services, including regulatory and study start-up, clinical trial monitoring, project management, early-phase and first-in-patient operational support, and GCP audit and inspection-readiness services.